このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Evaluating Effects of Group-based CBT for Emotion Regulation in Adult ADHD (GEARS)

2026年8月4日 更新者:Elinor Eskilsson Strålin、Karolinska Institutet

Group-based Emotion Regulation Skills Training for Adults With ADHD: GEARS, a Quantitative and Qualitative Investigation of Treatment Effects

This study will evaluate if a specific treatment for emotion regulation in ADHD, GEARS, effectively reduces symptoms of emotional dysregulation. GEARS will be evaluated through a randomized controlled trial (RCT) and a qualitative interview study.

This project aims to investigate two main questions:

  1. Is GEARS an effective treatment for emotion regulation difficulties in adult ADHD patients?
  2. How do participants perceive the impact of completing the GEARS treatment? Study 1 investigates research question 1 through an RCT comparing GEARS to a passive control group. Data are collected using validated measures before and after treatment/waiting period, as well as at six and 12 months follow ups.

Sample size: 150 participants, ensuring sufficient statistical power to detect significant between-group differences, even with some attrition.

Study 2 examines the patients' perspectives on the treatment by interviewing 15-20 participants about their experience with GEARS. The interviews focus on GEARS' perceived impact. Interviews will be recorded, transcribed, and analyzed using thematic analysis to identify key recurring themes.

調査の概要

詳細な説明

The trial will evaluate the GEARS manual. ADHD is one of the most common psychiatric diagnoses, with a growing demand for psychological treatment. Many adults seek help for impaired emotion regulation, yet evidence-based treatments are lacking. GEARS has shown promising results and addresses a critical need in psychiatric outpatient care. If proven effective in controlled studies, it could be widely implemented, enhancing functional outcomes in work and family life. Given the negative impact of emotion dysregulation, establishing evidence for this clinically developed and tested method is essential. Participants Inclusion criteria; (1) being diagnosed with ADHD according to DSM criteria, (2) age 18 years orabove, and (3) having identified problems with emotion regulation difficulties. Exclusion criteria: (1) diagnosis of intellectual disability, (2) diagnosis of autism (3) substance abuse, (4) severe mental illness (e.g., severe depression, anorexia) or comorbidity requiring clinical priority, (5) difficulties allocating time to participate due to social, academic or occupational circumstances hindering engagement in treatment, (6) other ongoing psychotherapy, and (7) difficulties accepting the group setting.

Treatment will take place within psychiatric outpatient clinics in regular care in Stockholm. Participants will be randomized to either start the intervention or to waitlist control. The GEARS is conducted in groups of around 8 participants led by two skilled therapist experienced in CBT and ADHD.

Inclusion criteria Treatment Method: GEARS is a new manual-based group treatment consisting of 14 weekly 2-hour sessions with eight participants and two group leaders. The group leaders, who are licensed psychologists or psychotherapists with CBT training and experience with this patient group, undergo training in the GEARS protocol prior to the start of treatment. The protocol is based on CBT with elements of DBT, ACT, and research on emotion theory and affect dysregulation in ADHD. The treatment is adapted to the needs of individuals with ADHD and designed to provide support so that executive difficulties do not become an obstacle to benefiting from the treatment.

In addition to the group sessions, each participant receives 30-60 minutes of coaching every other week with a group leader. The purpose is to support homework assignments, the application of treatment strategies in relation to individual challenges, and to strengthen the therapeutic process. Coaching sessions can take place on-site, via telephone, or via video.

The GEARS manual gives a clear agenda for the 14 group sessions and provides PowerPoint presentations, worksheets, and texts designed to increase understanding, acceptance, and regulation of emotions. The 14 sessions of the treatment are organized to cover the following themes:

Week 1: Introduction

Week 2: Mindfulness I + Acceptance

Week 3: Mindfulness II + The Normal Function of Emotions

Week 4: Mindfulness III + Emotional Awareness

Week 5: Primary and Secondary Emotions

Week 6: Self-reinforcement of Emotions / "Finished Behavior Analysis"

Week 7: Self-reinforcement of Emotions / "Finished Behavior Analysis"

Week 8: Impulse Control

Week 9: Emotional Control and Avoidance vs. Willingness and Acceptance

Week 10: Communication Skills

Week 11: Regulating Emotions Without Avoiding Them

Week 12: Valued Directions I + Relapse Prevention

Week 13: Valued Directions II

Week 14: Relapse Prevention / Termination

Measurements: Measures of emotion regulation and symptoms of ADHD, depression, anxiety and quality of life will be used to evaluate effects of treatment. Participants will be assessed pre, post and follow up at 6 and 12 months after treatment completion.

研究の種類

介入

入学 (推定)

150

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • being diagnosed with ADHD according to DSM criteria,
  • age 18 years or above, and
  • having identified problems with emotion regulation difficulties.

Exclusion Criteria:

  • diagnosis of intellectual disability,
  • diagnosis of autism
  • substance abuse,
  • severe mental illness (e.g., severe depression, anorexia) or comorbidity requiring clinical priority,
  • difficulties allocating time to participate due to social, academic or occupational circumstances hindering engagement in treatment,
  • other ongoing psychotherapy, and
  • difficulties accepting the group setting.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:GEARS intervention group
Group Therapy for Improving Emotional Acceptance and Regulatory Skills in Adults with ADHD (GEARS)
The GEARS protocol is the first CBT based group therapy protocol describing an intervention designed specifically to treat emotion regulation in ADHD.
介入なし:Control
Participants will wait for treatment for six months and provide data assessed at the same time points as the intervention group. Participants will receive treatment and be assessed after their treatment is completed but not at the follow ups.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Barkley Deficits in Executive Functioning Scale (B-DEFS) Deficits in emotion regulation subscale (DEFS-LF) : Self-regulation of Emotion using the subscale from the
時間枠:From pre-treatment to post treatment and follow up at 6 and 12 months past treatment end.
Measures emotion regulation difficulties through 13 items rated from 1 ("Never or rarely") to 4 ("Very often") range: 13-52
From pre-treatment to post treatment and follow up at 6 and 12 months past treatment end.
Difficulties in Emotion Regulation Scale (DERS)
時間枠:Assessment at pretreatment to post treatment at 15 week and after follow up at week 25. Follow up assessments at 6 and 12 months pat treatment end.
Measures symptoms of emotion regulation difficulties through 36 items rated in a five point scale, from 1(1= almost never) to 5, (5 = almost always) range 36-180.
Assessment at pretreatment to post treatment at 15 week and after follow up at week 25. Follow up assessments at 6 and 12 months pat treatment end.

二次結果の測定

結果測定
メジャーの説明
時間枠
The Hospital Anxiety and Depression Scale (HADS)
時間枠:From pretreatment to end of treatment at 25 weeks
Measuring symptoms of anxiety and depression through 14 questions, rated 0-3, range 0-42.
From pretreatment to end of treatment at 25 weeks
ASRS
時間枠:From pre-treatment to post treatment and follow up at 6 and 12 months past treatment end.
Measuring ADHD symptoms, 18 items rated 0 (0= never) to 4 (4= very often) range 0-72
From pre-treatment to post treatment and follow up at 6 and 12 months past treatment end.
Adult ADHD Quality of Life Scale (AAQoL)
時間枠:From pre-treatment to post treatment and follow up at 6 and 12 months past treatment end.
Measures different aspects of everyday life functioning through 21 questions, rated from 1 (not at all) to 5 (very much), range 21- 105.
From pre-treatment to post treatment and follow up at 6 and 12 months past treatment end.
Barkley Deficits in Executive Functions Scale Short Form (BDEFS-SF)
時間枠:up to 6 and 12 months past treatment end.
Measures executive functions in ADHD through 20 items rated from 1 (1= never or rarely) to 4 (very often) range 20-80.
up to 6 and 12 months past treatment end.

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Elinor Eskilsson Strålin, PhD、Department of Clinical Neuroscience, Karolinska Institutet (KI)

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年8月1日

一次修了 (推定)

2029年6月1日

研究の完了 (推定)

2029年6月1日

試験登録日

最初に提出

2026年5月22日

QC基準を満たした最初の提出物

2026年5月22日

最初の投稿 (実際)

2026年5月29日

学習記録の更新

投稿された最後の更新 (実際)

2026年8月5日

QC基準を満たした最後の更新が送信されました

2026年8月4日

最終確認日

2026年8月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • 2023-06542-01
  • 2024-04400-02, 2026-01733-02 (その他の識別子:Swedish Ethical Review Authority)

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する